Scrip
The changing climate for whistleblowers
07 September 2009
Peter Charlish
Please Login to read the full article.
07 September 2009
Peter Charlish
The $2.3 billion fine against
Pfizer announced last week (scripnews.com, September 3rd 2009) is expected to lead to far greater oversight of the way prescription drugs are marketed in the US. The record-breaking fine was a punishment for the off-label promotion of four products: the anti-inflammatory...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US high court seeks government views on J&J's appeal in Procrit kickback case
- US court dismisses Lipitor whistleblower suit against Pfizer
- Schering-Plough wins US dismissal of Intron A/Temodar off-label suit
- US Justice files suit charging J&J paid kickbacks to induce prescriptions
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
